Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read More
Chemistry & Life Sciences
Filter By
Lecanemab: could the drug with modest benefits make a big difference to Alzheimer’s patients?
Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…
Read More
What happens when your cosmetic method gives rise to therapeutic effects?
There are many innovations in the cosmetic sector that can be the subject of patent applications and these may be…
Read More
Data versus time in clinical trials: attaining the perfect balance
Clinical trials are an expensive and risky business. The investment of time, resources and costs grows with progression through the…
Read More
Can you keep a trade secret? Understanding pharmaceutical IP
Patents are the ‘go-to’ form of Intellectual Property (IP) protection for new pharmaceuticals. Through patents, protection can be attained for…
Read More
The verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…
Read More12